Short Interest in 3SBio Inc. (OTCMKTS:TRSBF) Decreases By 46.5%

3SBio Inc. (OTCMKTS:TRSBF) was the target of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 314,900 shares, a drop of 46.5% from the November 30th total of 589,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

3SBio Price Performance

Shares of TRSBF remained flat at $0.83 during midday trading on Friday. The company’s 50-day moving average is $0.74 and its 200 day moving average is $0.75. 3SBio has a 12-month low of $0.72 and a 12-month high of $0.77.

3SBio Company Profile

3SBio Inc, an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer; TNF, pre-filled aqueous injection solution.